Value Based Payment Shift for Independent Urology Practices: Roadmap and Barriers - 05/01/23
Doi : 10.1016/j.urology.2022.10.008
Vishnukamal Golla a, b, c, i, ⁎ 
, Charles D. Scales a, b, c, David Johnson d, e, Alan L. Kaplan g, h, CJ Stimson f, Mark McClellan b, Robert Saunders b
, Charles D. Scales a, b, c, David Johnson d, e, Alan L. Kaplan g, h, CJ Stimson f, Mark McClellan b, Robert Saunders b a National Clinician Scholars Program, Duke University, Durham, NC
b Duke-Margolis Center for Health Policy, Duke University, Durham, NC
c Department of Surgery, Division of Urology, Duke University School of Medicine, Durham, NC
d Department of Urology, University of North Carolina School of Medicine, Chapel Hill, NC
e Rubicon Founders, Nashville, TN
f Department of Urology ,Vanderbilt University, Nashville, TN
g Department of Urology,Georgetown University School of Medicine, Department of Urology, Washington, DC
h Veterans Affairs Medical Center, Department of Surgery, Washington, DC
i Department of Surgery, Section of Urology, Durham VA, Durham, NC
⁎Address correspondence to: Vishnukamal Golla, Duke-Margolis Center for Health Policy, Duke University, Durham, NC 27708.Duke-Margolis Center for Health PolicyDuke UniversityDurhamNC27708
Le texte complet de cet article est disponible en PDF.
Plan
| Funding: This article is part of a collaborative initiative between the Duke-Margolis Center and West Health. Dr. Saunders has a consulting agreement with Yale-New Haven Health System for development of measures and development of quality measurement strategies for the Innovation Center Alternative Payment Models under CMS contract No. 75FCMC18D0042/Task Order No. 75FCMC19F0003, “Quality Measure Development and Analytic Support,” Option Year 2. Dr. McClellan is an independent director on the boards of Johnson & Johnson, Cigna, Alignment Health care, and PrognomIQ; co-chairs the Guiding Committee for the Health Care Payment Learning and Action Network; and receives fees for serving as an adviser for Arsenal Capital Partners, Blackstone Life Sciences, and MITRE. |
|
| Disclaimers: This study has not been presented in part at a major research meeting prior to submission for publication. |
© 2022
Elsevier Inc. Tous droits réservés.
Vol 171
P. 1-5 - janvier 2023 Retour au numéro
Article précédent
- Table of Contents
- History of the Relationship Between Smoking and Bladder Cancer: A Public Health Perspective
- Kristin G. Weiss, Richard S. Matulewicz, Elizabeth Moreton, Kimberly A. Shoenbill, Matthew I. Milowsky, Tracy L. Rose, William Y. Kim, Adam O. Goldstein, Marc A. Bjurlin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?